Biomaterial Database

Procaineamide blood levels after administration of a sustained-release preparation. 1977

E Cunningham, and G Sloman

Procaineamide is now available as a sustained-release preparation. This preparation was administered in an eight-hourly regime to 26 patients, and therapeutic blood levels were obtained for the duration of the 56-hour study period in 20 patients. No side effects were observed. Inadequate blood levels may be predicted from a single blood level eight hours after the first dose, which could allow for dosage adjustment.

UI	MeSH Term	Description	Entries
D011342	Procainamide	A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.	Procaine Amide,Apo-Procainamide,Biocoryl,Novocainamide,Novocamid,Procainamide Hydrochloride,Procamide,Procan,Procan SR,Procanbid,Pronestyl,Rhythmin,Amide, Procaine,Hydrochloride, Procainamide
D003692	Delayed-Action Preparations	Dosage forms of a drug that act over a period of time by controlled-release processes or technology.	Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001145	Arrhythmias, Cardiac	Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.	Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D013997	Time Factors	Elements of limited time intervals, contributing to particular results or situations.	Time Series,Factor, Time,Time Factor

Related Publications

E Cunningham, and G Sloman

Papaverine blood levels after administration of a sustained-release preparation. Short communication.

January 1977, Arzneimittel-Forschung,

E Cunningham, and G Sloman

Theophylline serum levels unmodified by postprandial administration of a sustained-release preparation (Teonova).

January 1988, International journal of clinical pharmacology research,

E Cunningham, and G Sloman

Blood levels and bioavailability of ascorbic acid after administration of a sustained-release formulation to humans.

January 1977, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,

E Cunningham, and G Sloman

Correlation of serum and saliva theophylline concentration after administration of a sustained release preparation.

January 1981, European journal of clinical pharmacology,

E Cunningham, and G Sloman

Quantitation of nitroglycerin in human blood after administration by sustained release.

May 1978, Experientia,

E Cunningham, and G Sloman

Blood levels from a sustained-release dosage form.

October 1975, Journal of pharmaceutical sciences,

E Cunningham, and G Sloman

[Plasma sulfonamide levels and sulfonamide excretion in cattle following administration of "sustained--release" sulfamethacine preparation].

October 1971, DTW. Deutsche tierarztliche Wochenschrift,